These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 9264010

  • 1. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
    Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J.
    Kidney Int; 1997 Aug; 52(2):509-16. PubMed ID: 9264010
    [Abstract] [Full Text] [Related]

  • 2. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 3. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
    Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J.
    PLoS One; 2014 Jul 13; 9(2):e99026. PubMed ID: 24918438
    [Abstract] [Full Text] [Related]

  • 4. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.
    Kidney Int; 2007 Jun 13; 71(11):1148-54. PubMed ID: 17342176
    [Abstract] [Full Text] [Related]

  • 5. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 13; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 6. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
    Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, Brown R, Hall S, Kilian M, Poulsen K, Mestecky J, Julian BA, Novak J.
    Mol Immunol; 2007 Apr 13; 44(10):2598-604. PubMed ID: 17275907
    [Abstract] [Full Text] [Related]

  • 7. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Jan 11; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 9. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Jan 11; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 10. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 11; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 11. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 11; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 12. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX, Zhao MH.
    Kidney Int; 2005 Jul 11; 68(1):167-72. PubMed ID: 15954905
    [Abstract] [Full Text] [Related]

  • 13. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr 11; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 14. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2009 Jun 11; 119(6):1668-77. PubMed ID: 19478457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
    Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R.
    Clin J Am Soc Nephrol; 2011 Aug 11; 6(8):1903-11. PubMed ID: 21784819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
    Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y.
    BMC Nephrol; 2014 Jun 13; 15():89. PubMed ID: 24928472
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
    Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.
    Pediatr Nephrol; 2007 Dec 13; 22(12):2067-72. PubMed ID: 17943324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.